Wu; Joseph C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Joseph C..The latest application filed is for "methods for determining risk of developing insulin resistance".

Company Profile

8.12.10

Wu; Joseph C. - Stanford CA
WU; Joseph C. - Palo Alto CA
Wu; Joseph C. - Utica NY
Wu; Joseph C. - Saratoga CA
Wu; Joseph C. - Sunnyvale CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Determining Risk Of Developing Insulin Resistance App 20220273591 - Wu; Joseph C. ; et al.	2022-09-01
Pharmaceutical Compositions And Methods For Countering Chemotherapy Induced Cardiotoxicity App 20220133684 - ARMSTRONG; Christopher G. ; et al.	2022-05-05
IPSC-based vaccine as a prophylactic and therapeutic treatment for cancer Grant 11,298,380 - Kooreman , et al. April 12, 2	2022-04-12
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity Grant 11,166,936 - Armstrong , et al. November 9, 2	2021-11-09
Pharmaceutical Compositions And Methods For Countering Chemotherapy Induced Cardiotoxicity App 20210121436 - ARMSTRONG; Christopher G. ; et al.	2021-04-29
Ge-doped Ausn Solder Alloys App 20210047710 - Wu; Joseph C. ; et al.	2021-02-18
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity Grant 10,874,633 - Armstrong , et al. December 29, 2	2020-12-29
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity Grant 10,806,716 - Armstrong , et al. October 20, 2	2020-10-20
Pharmaceutical Compositions And Methods For Countering Chemotherapy Induced Cardiotoxicity App 20200253920 - Kind Code	2020-08-13
Prevention and Treatment of Teratoma Formation in Stem Cell-Based Therapies Using Alternating Electric Fields App 20200121728 - WARDAK; Mirwais ; et al.	2020-04-23
Ipsc-based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer App 20190290697 - Kooreman; Nigel G. ; et al.	2019-09-26
Pharmaceutical Compositions and Methods for Countering Chemotherapy Induced Cardiotoxicity App 20190175544 - Armstrong; Christopher G. ; et al.	2019-06-13
Pharmaceutical Compositions And Methods For Countering Chemotherapy Induced Cardiotoxicity App 20170224654 - Armstrong; Christopher G. ; et al.	2017-08-10
ShRNA gene therapy for treatment of ischemic heart disease Grant 8,680,064 - Wu , et al. March 25, 2	2014-03-25
Novel Shrna Gene Therapy For Treatment Of Ischemic Heart Disease App 20120004283 - Wu; Joseph C. ; et al.	2012-01-05
Frequency modulated radio frequency broadcast network employing a synchronous frequency modulated booster system Grant RE34,540 - Wu , et al. February 8, 1	1994-02-08
Frequency modulated radio frequency broadcast network employing a synchronous frequency modulated booster system Grant 5,065,450 - Wu , et al. November 12, 1	1991-11-12
Frequency modulated radio frequency broadcast network employing a synchronous frequency modulated booster system Grant 5,046,124 - Wu , et al. September 3, 1	1991-09-03
Method of and apparatus for generating a frequency modulated ultrahigh frequency radio transmission signal Grant 4,710,970 - Wu , et al. December 1, 1	1987-12-01
Apparatus for monitoring television receivers Grant 4,027,332 - Wu , et al. May 31, 1	1977-05-31
Frequency And Modulation Monitor Grant 3,736,510 - Wu May 29, 1	1973-05-29

Company Registrations

NCAGE Code	46K62	WU JOSEPH C
NCAGE Code	8HBM1	WU, JOSEPH C
CAGE Code	8HBM1	WU, JOSEPH C
CAGE Code	46K62	WU, JOSEPH C
S.A.M. Registration	8HBM1 [117417093]	WU, JOSEPH C

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.